137 related articles for article (PubMed ID: 29649536)
1. Characterization of Momordica charantia L. polysaccharide and its protective effect on pancreatic cells injury in STZ-induced diabetic mice.
Zhang C; Chen H; Bai W
Int J Biol Macromol; 2018 Aug; 115():45-52. PubMed ID: 29649536
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of selenylated polysaccharides from Momordica charantia L. and its hypoglycemic activity in streptozotocin-induced diabetic mice.
Ru Y; Liu K; Kong X; Li X; Shi X; Chen H
Int J Biol Macromol; 2020 Jun; 152():295-304. PubMed ID: 32112833
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic properties of Momordica charantia L. polysaccharide in alloxan-induced diabetic mice.
Xu X; Shan B; Liao CH; Xie JH; Wen PW; Shi JY
Int J Biol Macromol; 2015 Nov; 81():538-43. PubMed ID: 26318666
[TBL] [Abstract][Full Text] [Related]
4. Preparation of a Momordica charantia L. polysaccharide‑chromium (III) complex and its anti-hyperglycemic activity in mice with streptozotocin-induced diabetes.
Zhang C; Huang M; Hong R; Chen H
Int J Biol Macromol; 2019 Feb; 122():619-627. PubMed ID: 30391593
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide from fermented Momordica charantia L. with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats.
Gao H; Wen JJ; Hu JL; Nie QX; Chen HH; Xiong T; Nie SP; Xie MY
Carbohydr Polym; 2018 Dec; 201():624-633. PubMed ID: 30241862
[TBL] [Abstract][Full Text] [Related]
6. Effects of Momordica charantia on pancreatic histopathological changes associated with streptozotocin-induced diabetes in neonatal rats.
Abdollahi M; Zuki AB; Goh YM; Rezaeizadeh A; Noordin MM
Histol Histopathol; 2011 Jan; 26(1):13-21. PubMed ID: 21117023
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Notch signaling and angiogenesis via an isolated polysaccharide from Momordica charantia in diabetic rats.
Sajadimajd S; Mohammadi B; Bahrami G; Madani SH; Hatami R; Miraghaee SS
J Food Biochem; 2022 Feb; 46(2):e14033. PubMed ID: 34964144
[TBL] [Abstract][Full Text] [Related]
8. Momordica charantia polysaccharides mitigate the progression of STZ induced diabetic nephropathy in rats.
Raish M; Ahmad A; Jan BL; Alkharfy KM; Ansari MA; Mohsin K; Jenoobi FA; Al-Mohizea A
Int J Biol Macromol; 2016 Oct; 91():394-9. PubMed ID: 27238589
[TBL] [Abstract][Full Text] [Related]
9. Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice.
Wang Q; Wu X; Shi F; Liu Y
Biomed Pharmacother; 2019 Jan; 109():744-750. PubMed ID: 30551527
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat.
Ahmed I; Adeghate E; Cummings E; Sharma AK; Singh J
Mol Cell Biochem; 2004 Jun; 261(1-2):63-70. PubMed ID: 15362486
[TBL] [Abstract][Full Text] [Related]
11. Differential anti-diabetic effects and mechanism of action of charantin-rich extract of Taiwanese Momordica charantia between type 1 and type 2 diabetic mice.
Wang HY; Kan WC; Cheng TJ; Yu SH; Chang LH; Chuu JJ
Food Chem Toxicol; 2014 Jul; 69():347-56. PubMed ID: 24751968
[TBL] [Abstract][Full Text] [Related]
12. Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
Mahmoud MF; El Ashry FE; El Maraghy NN; Fahmy A
Pharm Biol; 2017 Dec; 55(1):758-765. PubMed ID: 28064559
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of Momordica charantia seeds in the treatment of STZ-induced diabetes in experimental rats.
Sathishsekar D; Subramanian S
Biol Pharm Bull; 2005 Jun; 28(6):978-83. PubMed ID: 15930730
[TBL] [Abstract][Full Text] [Related]
14. Protective effects and mechanisms of Momordica charantia polysaccharide on early-stage diabetic retinopathy in type 1 diabetes.
Liu J; Liu Y; Sun J; Guo Y; Lei Y; Guo M; Wang L
Biomed Pharmacother; 2023 Dec; 168():115726. PubMed ID: 37862973
[TBL] [Abstract][Full Text] [Related]
15. Antioxidant activity of Momordica charantia polysaccharide and its derivatives.
Chen F; Huang G; Yang Z; Hou Y
Int J Biol Macromol; 2019 Oct; 138():673-680. PubMed ID: 31344411
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of polysaccharides from Lilium lancifolium on streptozotocin-induced diabetic mice.
Zhang T; Gao J; Jin ZY; Xu XM; Chen HQ
Int J Biol Macromol; 2014 Apr; 65():436-40. PubMed ID: 24508917
[TBL] [Abstract][Full Text] [Related]
17. Rehmannia glutinosa (Gaertn.) DC. polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice.
Zhou J; Xu G; Yan J; Li K; Bai Z; Cheng W; Huang K
J Ethnopharmacol; 2015 Apr; 164():229-38. PubMed ID: 25698243
[TBL] [Abstract][Full Text] [Related]
18. Preparation, analysis, antioxidant activities in vivo of phosphorylated polysaccharide from Momordica charantia.
Chen F; Huang G; Huang H
Carbohydr Polym; 2021 Jan; 252():117179. PubMed ID: 33183626
[TBL] [Abstract][Full Text] [Related]
19. Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.
Bai W; Zhang C; Chen H
Gene; 2018 Oct; 675():208-216. PubMed ID: 30180967
[TBL] [Abstract][Full Text] [Related]
20. [The hypoglycemic effects of crude polysaccharides extract from Momordica charantia in mice].
Zheng ZX; Teng JY; Liu JY; Qiu JH; Ouyang H; Xue C
Wei Sheng Yan Jiu; 2005 May; 34(3):361-3. PubMed ID: 16111053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
